Labcorp Holdings Inc.
S&P 500LH/Healthcare · Diagnostics & Research/NYSE
Dividend Yield
1.13%
$2.88 · Annual Dividend
Dividend Safety Rating
LH's dividend appears safe and well-supported. Strengths include a 25.5% earnings payout ratio & 17.4% fcf payout ratio. Areas of concern: Volatile profit margin stability & 0.0% 5-year dividend cagr.
Based on 15 of 15 metrics
Strengths
- Earnings Payout Ratio: 25.5%Low earnings payout ratio leaves room to grow the dividend.
- FCF Payout Ratio: 17.4%Free cash flow comfortably covers the dividend.
- CFO Payout Ratio: 12.1%Operating cash flow strongly supports the payout.
Risks
- Profit Margin Stability: VolatileProfit margins have been volatile.
- 5-Year Dividend CAGR: 0.0%Dividend growth has been weak or negative.
Payout & Coverage
Very SafeBalance Sheet
SafeProfitability
CautionDividend Track Record
SafeAbout Labcorp Holdings Inc.
Labcorp Holdings Inc. is a leading provider of laboratory services, operating through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. It delivers a comprehensive array of diagnostic tests, including blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures, and substance-abuse screenings. The company also specializes in advanced esoteric testing, such as gene-based diagnostics, molecular residual disease testing for cancers like breast, lung, and colon, and innovative blood tests to rule out Alzheimer's-related amyloid pathology. Labcorp Holdings Inc. supports physicians, hospitals, pharmaceutical firms, researchers, and patients with routine and complex clinical lab services, including oncology, genomic testing, and digital pathology platforms. These offerings enable clear decision-making in healthcare, from primary care to specialized biopharma research. Headquartered in Burlington, North Carolina, the company maintains an extensive network of patient service centers and collaborations to advance diagnostic efficiency and patient outcomes.
Dividend Overview
Dividend Yield
1.13%
Annual Dividend
$2.88
Frequency
Quarterly
Payout Ratio
25.51%
FCF Payout Ratio
17.36%
52-Week Range
$241.81 - $293.72
Dividend History (2016–2025)
LH annual dividend per share and yield history
Earnings & Profitability
LH earnings per share and net profit margin
Key Dates
Last Ex-Dividend Date
May 29, 2026
Last Payment Date
June 11, 2026
Dividend Growth
3-Year Dividend CAGR
15.78%
5-Year Dividend CAGR
0.00%
10-Year Dividend CAGR
0.00%
3-Year Total Growth
55.20%
5-Year Total Growth
0.00%
10-Year Total Growth
0.00%
Income Calculator
Similar Dividend Stocks
Frequently Asked Questions
What is LH's current dividend yield?
When is LH's next dividend payment date?
How much does LH pay in dividends per year?
Has LH been increasing its dividend?
Is LH's dividend safe?
How is LH's Dividend Safety Rating calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track LH Dividends with OnlyDividends
What will LH actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.